Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1971-7-27
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0032-3756
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
764-6
|
pubmed:dateRevised |
2008-6-20
|
pubmed:meshHeading |
pubmed-meshheading:5580934-Ampicillin,
pubmed-meshheading:5580934-Bacteria,
pubmed-meshheading:5580934-Cephaloridine,
pubmed-meshheading:5580934-Cloxacillin,
pubmed-meshheading:5580934-Drug Synergism,
pubmed-meshheading:5580934-Humans,
pubmed-meshheading:5580934-Penicillin G,
pubmed-meshheading:5580934-Urinary Tract Infections
|
pubmed:year |
1971
|
pubmed:articleTitle |
[Synergistic activity of cloxacillin (Syntarpen 201) with other beta-lactam antibiotics against Gram-negative enteric bacteria].
|
pubmed:publicationType |
Journal Article
|